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Background: Besides the established guidelines, different region-specific recommenda-
tions for the use of DES exist worldwide, most are restricted to high-risk patients groups.
Our aim was to evaluate the current PCI practice in a large population of patients in a real
world clinical setting focusing on three main regions: Europe, Asia and Latin-America.
Methods: e-NOBORI is a prospective, multinational, single-arm, multi-centre, observa-
tional registry. A total of 6087 patients have been enrolled in Europe, 887 in Asia and 776
in Latin-America. The primary endpoint of the study is target lesion failure (TLF) a
composite of cardiac death (CD), target vessel myocardial infarction (MI) and target
lesion revascularisation (TLR).
Results: Patients: In Europe were oldest (6312), with highest history of PCI (31%), and
frequency of occluded and calcified lesions; In Asia were the youngest (5711), more
often diabetic (41%) with highest prevalence of multivessel disease (21%) and chronically
occluded lesions (6%); and in Latin-America were more often female (25%), with the
lowest number of lesions treated. Treatment of AMI was highest in Europe (30%) and
lowest in Asia (9%), while distribution of left main (2%) and true bifurcation (5.5%)
was similar. Pre- and post-dilatation were more often performed in Asia while Europe
presented the highest rate of radial access (57%) and direct stenting (40%) with the lowest
rate of post-dilatation (28%). At 1-month the rate of CD was 0,2%, 0,3% and 0,9%, MI
0,6%, 0,0% and 0,8% and TLR 0.8%, 0.0% and 0.0% for Europe, Asia and Latin-
America, respectively. The TLF was 0,7%, 0,3% and 1.8%. Stent thrombosis frequency
will be added at the time of the presentation along with fully adjudicated adverse events
at 1-month and 1-year.
Conclusions: Interesting findings were observed related to regional differences in
procedure characteristics and complexity of the patients and lesions. Despite these
differences the procedural success was over 99% for all three regions and the preliminary
clinical outcomes showed similarly low TLF rate in this complex, all comer’s population,
treated with Nobori DES, in three continents.
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Background: The clinical importance of ad hoc percutaneous coronary intervention
(PCI), which combines coronary angioplasty and PCI in the same procedure, in the era of
drug-eluting stents (DES) has not been fully evaluated.
Methods: From the IRIS-DES registry, 4738 angina patients treated using PCI with DES
were enrolled. The 18-month outcomes were compared between ad hoc and non-ad hoc
groups after adjusting using inverse-probability-of-treatment weighting.
Results: Ad hoc PCI was performed in 3562 (75.2%) patients. The ad hoc PCI group had
less extensive coronary disease and received fewer stents. The incidence of major adverse
cardiac or cerebrovascular events (MACCE) consisting of death, myocardial infarction
(MI), stroke, or repeat revascularization did not differ between the ad hoc and non-ad hoc
groups (8.3% vs. 7.6%; adjusted hazard ratio [aHR] of ad hoc PCI, 1.22; 95% confidence
interval [CI], 0.91 to 1.63; P0.18). The individual end points of death (2.0% vs. 1.9%;
aHR, 1.57; 95% CI, 0.86 to 2.88; P0.14), MI (0.8% vs. 1.0%; aHR, 0.62; 95% CI, 0.29
to 1.33; P0.22), stroke (1.0% vs. 0.9%; aHR, 1.25; 95% CI, 0.58 to 2.69; P0.57), and
repeat revascularization (4.4% vs. 4.0%; aHR, 1.23; 95% CI, 0.86 to 1.77; P0.25) also
did not differ between the groups.
Conclusions: Ad hoc PCI using DES appears to be feasible for angina patients at a
relatively low-risk of procedure. This approach may be reasonably performed with
evaluation of objective ischemia using noninvasive or invasive tests.
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Background: Although direct stenting has become a daily practice and been proposed as
an alternative for conventional stenting with predilatation, there have been no randomized
evaluations using bare metal and drug eluting stents in elective PCI patients. The aim of
this study was to assess clinical outcome of a strategy of direct stenting without
pre-dilatation compared to conventional stenting with pre-dilatation or provisional
stenting.
Methods: A total of 1360 patients with stable or unstable angina pectoris or a recent
(30 days) myocardial infarction with objective evidence of myocardial ischemia were
randomized to direct stenting, stenting after pre-dilatation or a provisional stenting
strategy. The primary endpoint was the mean minimal lumen diameter (MLD) at
follow-up angiography. The secondary endpoint was the clinical procedural success
defined as angiographic success without major adverse cardiac events (MACE) at 9
months follow-up.
Results: Follow-up angiography was performed in 367/736 pts in the BMS and in
524/532 pts in the DES cohort. Stents were used in 57.8% (BMS) and 77.5% (DES) of
patients in the provisional arm.
Direct Conventional Provisional p-value
Drug Eluting
Stent
9 month follow
up
MLD, mm 2.12 0.58 2.17 0.67 1.99 0.69 0.059
MACE 18/192 (9.4%) 9/197 (4.6%) 17/197 (8.6%) 0.152
Bare Metal
Stent
6 month
angiographic
and 9 month
clinical follow up
MLD, mm 1.77 0.54 1.79 0.64 1.63 0.61 0.224
MACE 19/245 (7.8%) 20/241 (8.3%) 27/243 (11.1%) 0.383
BMS	DES Direct Conventional Provisional p-value
MACE 28/433 (6.5%) 25/436 (5.7%) 31/438 (7.1) 0.720
Conclusions: Direct stenting, when compared to conventional DES or BMS stenting did
not reduce angiographic restenosis. Provisional stenting was associated with a higher rate
of restenosis in the DES group only. No differences were observed in the rate of MACE
during follow up within the different strategies.
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